Evidence map›Paper›PMID 29725086›Full record

ArticleScientific reports2018

Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients.

Chung-Feng Kao, Yu-Li Liu, Younger W-Y Yu, Albert C Yang, Eugene Lin, Po-Hsiu Kuo, Shih-Jen Tsai

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Chung-Feng KaoDepartment of Agronomy, National Chung Hsing University, Taichung, Taiwan.
Yu-Li LiuCenter for Neuropsychiatric Research, National Health Research Institutes, Miaoli County, Taiwan.
Younger W-Y YuYu's Psychiatric Clinic, Kaohsiung, Taiwan.
Albert C YangDepartment of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Eugene LinGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Po-Hsiu KuoDepartment of Public Health, Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan. phkuo@ntu.edu.tw.
Shih-Jen TsaiDepartment of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan. tsai610913@gmail.com.ORCID 0000-0002-9987-022X
Beth Israel Deaconess Medical Center · USChina Medical University · TWNational Chung Hsing University · TWNational Health Research Institutes · TWNational Taiwan University · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well established that brain-derived neurotrophic factor (BDNF) signaling pathway plays a key role in the pathophysiology of major depressive disorder (MDD) and in therapeutic mechanisms of antidepressants. We aim to identify genetic vairiants related to MDD susceptibility and antidepressant therapeutic response by using gene-based association analysis with genes related to the neurotrophic pathway. The present study investigated the role of genetic variants in the 10 neurotrophic-related genes (BDNF, NGFR, NTRK2, MTOR, VEGFA, S100A10, SERPINE1, ARHGAP33, GSK3B, CREB1) in MDD susceptibility through a case-control (455 MDD patients and 2,998 healthy controls) study and in antidepressant efficacy (n = 455). Measures of antidepressant therapeutic efficacy were evaluated using the 21-item Hamilton Rating Scale for Depression. Our single-marker and gene-based analyses with ten genes related to the neurotrophic pathway identified 6 polymorphisms that reached a significant level (p-value < 5.0 × 10

Indexed as

Pharmacogenomic TestingAntidepressive AgentsBrain-Derived Neurotrophic FactorCase-Control StudiesDepressionHumansPolymorphism, GeneticTreatment OutcomeVascular Endothelial Growth Factor AAntidepressive AgentsBDNF protein, humanBrain-Derived Neurotrophic FactorVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID29725086
PMCPMC5934385
OpenAlexW2807507312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.